http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018030810-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e43b4ca6b41ce9f54c9a895d474c81a
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
filingDate 2016-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ea98d426b1fc33f12a7ba3dda073218
publicationDate 2018-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2018030810-A
titleOfInvention Method for producing pharmaceutical tablet containing gefitinib as an active ingredient
abstract PROBLEM TO BE SOLVED: To provide a method for producing a pharmaceutical tablet comprising gefitinib as an active ingredient and having no change in dissolution even in a neutral range, and capable of maintaining the content uniformity The task is to do. In particular, an object of the present invention is to provide a method for producing a pharmaceutical tablet which has no change in dissolution property in the neutral range and can maintain the uniformity of the content of the binder. SOLUTION: It includes a first step of mixing gefitinib and a solid binder, a second step of preparing a granulated body by adding an aqueous medium, and a third step of compressing the granulated body to obtain a pharmaceutical tablet. A method for producing a pharmaceutical tablet. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108096251-A
priorityDate 2016-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421153761
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631

Total number of triples: 24.